MCKESSON CORP
10-Q/A, 1995-03-20
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: VALCOR INC, 10-K, 1995-03-20
Next: ALBA WALDENSIAN INC, 8-K, 1995-03-21



               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549

 
                           FORM 10-Q/A


(Mark One)

[ X ]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                  THE SECURITIES EXCHANGE ACT OF 1934


For quarter ended December 31,  1994


[   ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                  THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from              to 
                               ------------    ------------

Commission file number 1-13252


                      McKESSON CORPORATION
     ------------------------------------------------------
     (Exact name of Registrant as specified in its charter)

           DELAWARE                            94-3207296
 -----------------------------     ------------------------------ 
(State or other jurisdiction of   (IRS Employer Identification No.)
 incorporation or organization)

   One Post Street, San Francisco, California           94104
   ----------------------------------------------------------
   (Address of principal executive offices)        (Zip Code)

                         (415) 983-8300
      ----------------------------------------------------
      (Registrant's telephone number, including area code)
                                

Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.

                       Yes  [ X ]     No  [   ]


Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date. 

          Class                Outstanding at December 31, 1994
- ----------------------------   --------------------------------
Common stock, $.01 par value            43,929,298 shares




The undersigned registrant hereby amends the items, financial
statements, exhibits or other portions of its Form 10-Q for the
quarter ended December 31, 1994 as set forth below.




                      LIST OF ITEMS AMENDED
                      =====================


1.   Amendment of Exhibit 27




                       TEXT OF AMENDMENTS
                       ==================


1.   Amendment of Exhibit 27
     -----------------------

     The purpose of this amendment is to properly file Exhibit 27. 
Exhibit 27 is hereby amended by deleting the exhibit in its
entirety and replacing it with Exhibit 27 attached hereto and filed
herewith.




Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this amendment to be signed on
its behalf by the undersigned, thereunto duly authorized.


                              McKesson Corporation
                               (Registrant)

March 20, 1995                /s/Nancy A. Miller
                              -----------------------------
                              Nancy A. Miller
                              Vice President and Secretary

WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

                      McKESSON CORPORATION
                     FINANCIAL DATA SCHEDULE
                        December 31, 1994
             (in millions except per share amounts)
       
<CAPTION>

     This schedule contains summary financial information extracted from the
McKesson Corporation Consolidated Financial Statements as of December 31, 1994
and March 31, 1994 and for the nine months ended December 31, 1994 and 1993 and
is qualified in its entirety by reference to such financial statements.


REGULATION
NUMBER         STATEMENT CAPTION                             FY95      FY94 
- -------------  -----------------                             ----      ----

<S>            <C>                                         <C>       <C> 

5-02(1)        Cash and cash items                         $  144.2  $   89.0 
5-02(2)        Marketable securities                          496.1         - 
5-02(3)(a)(1)  Accounts receivable - trade                    891.2     775.2 
5-02(4)        Allowance for doubtful accounts                (64.7)    (30.8)
5-02(6)        Inventory                                    1,219.4     993.5 
5-02(9)        Total current assets                         2,759.7   1,873.5 
5-02(13)       Property, plant and equipment                  749.9     788.1 
5-02(14)       Accumulated depreciation                      (398.9)   (391.5)
5-02(18)       Total assets                                 3,505.1   2,835.0 
5-02(21)       Total current liabilities                    1,786.6   1,428.2 
5-02(22)       Bonds, mortgages and similar debt              459.4         - 
5-02(28)       Preferred stock - mandatory redemption             -         - 
5-02(29)       Preferred stock - no mandatory redemption          -     125.3 
5-02(30)       Common stock                                      .4      89.2 
5-02(31)       Other stockholders' equity                     989.2     464.1 
5-02(32)       Total liabilities & stockholders' equity     3,505.1   2,835.0 
5-03(b)(1)(a)  Net sales of tangible products               9,841.0   9,126.9 
5-03(b)(1)     Total revenues                               9,841.0   9,126.9 
5-03(b)(2)(a)  Cost of tangible goods sold                  9,060.4   8,345.8 
5-03(b)(2)     Total costs & exp. appl. to sales & revenues 9,060.4   8,345.8 
5-03(b)(3)     Other costs and expenses                           -         - 
5-03(b)(5)     Provision for doubtful accounts & notes         44.2       6.2 
5-03(b)(8)     Interest & amortization of debt discount        33.6      30.7 
5-03(b)(10)    Income before taxes & other items             (144.7)    164.7 
5-03(b)(11)    Income tax expense                             (81.5)    (64.5)
5-03(b)(14)    Income/loss from continuing operations        (232.8)     95.3 
5-03(b)(15)    Discontinued operations                        597.7      21.4 
5-03(b)(17)    Extraordinary items                                -      (4.2)
5-03(b)(18)    Cumulative effect-chngs. in acctg. prin.           -     (16.7)
5-03(b)(19)    Net income or loss                             364.9      95.8 
5-03(b)(20)    Earnings per share - primary                    8.49      2.23 
5-03(b)(20)    Earnings per share - fully diluted              8.05      2.11 

        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission